Clinical trial of Scone device for overactive bladder still enrolling
Enrollment is nearly complete in a clinical trial of the SconeĀ neuromodulation device in treating neurogenic, or overactive, bladder due to multiple sclerosis (MS), stroke, or spinal cord injury, SpineX, its developer, announced. Currently, 95 adult patients (more than 80% of planned total), ages 18 to…